Mergers & Acquisitions
U.S. District Court, Eastern District of New York
U.S. District Court, Southern District of New York
University of Michigan Law School - J.D., 2006
Duke University - A.B., 2003
Braden McCurrach is a partner in Cadwalader’s Corporate Group. His practice involves counseling clients in a broad range of transactional matters, including public and private mergers, acquisitions, divestitures, proxy contests, tender offers, spinoffs and joint ventures. Braden’s practice also includes the representation of investment banks in their capacity as financial advisors on M&A and other transactions. In addition to his transactional experience, Braden advises clients in a wide array of governance, securities and other commercial matters, including directors’ duties and responsibilities, board composition, disclosure issues and compliance. Braden also advises clients on complex transactions involving distressed companies and assets, including mergers, acquisitions, investments and financings, as well as restructurings.
Recently named a “Key Individual” for his work in M&A: Large Deals by The Legal 500 US, Braden also has been recognized from 2013-2019 by Super Lawyers as a New York Metro mergers and acquisitions “Rising Star.” He received his A.B. from Duke University and his J.D. from the University of Michigan Law School. Braden McCurrach is admitted to practice law in the State of New York as well as in the U.S. District Court for the Southern District of New York and the U.S. District Court for the Eastern District of New York.
- Ashford Hospitality Trust in its successful defense against an activist campaign by Cygnus Capital and related litigation that resulted in the withdrawal by Cygnus of all of its director nominations for election at the company’s annual meeting
- Hudson Executive Capital in its agreement, along with Apollo Global Management, to acquire Cardtronics plc for $2.3 billion
- Monocle Acquisition Corporation in its merger with AerSale Corp.
- AngioDynamics, Inc. in the $167.5 million sale of its NAMIC® fluid management portfolio to Medline Industries, Inc.
- Inteva Products in the sale of its roof systems design and assembly business to CIE Automotive
- Hudson Executive Capital in its proxy contest and related litigation with USA Technologies Inc. and its successful effort to add eight new directors, including Hudson Executive founder Douglas Braunstein, to the company’s board
- The Howard Hughes Corporation in a Rule 144A/Reg S offering of $750 million aggregate principal amount of 5.375% senior notes
- SRS Investment Management in the renewal of its cooperation agreement with Avis Budget Group, Inc.
- Investors Nathan Miller and Peter O’Malley in their successful effort to replace the entire board of directors of Destination Maternity Corporation with a majority-female slate
- Activist investor Paul Hilal’s Mantle Ridge LP in its investment in CSX Corporation and successful effort to install Hunter Harrison as the company’s CEO and to add five new directors, including Hilal and Harrison, to the company’s board
- Ashford Hospitality Prime, Inc. in its proxy contest and related litigation against activist hedge fund Sessa Capital, which sought unsuccessfully to replace a majority of the company’s board
- The Pasha Group in its acquisition of the Hawaii trade-lane business of Horizon Lines
- Medifast in its agreement with Engaged Capital
- Cigna Corporation in connection with the public offering of $900 million of 3.250% Senior Notes due 2025
- Jos. A. Bank’s financial advisor in connection with its agreement to acquire Eddie Bauer and its subsequent sale to Men’s Wearhouse
- Air Products and Chemicals in its agreement with Pershing Square Capital Management following the 9.8% investment position taken by Bill Ackman
- Dell’s financial advisor in connection with its $24.9 billion acquisition by Michael Dell and Silver Lake Partners
- Élan in the $3.25 billion sale of its interest in TYSABRI to Biogen Idec
- The United States Department of the Treasury in the management of its $250 billion TARP Capital Purchase Program
- Triarco Industries in its sale to Innophos
- AngioDynamics in its acquisitions of RadiaDyne, the BioSentry Tract Sealant assets of Surgical Specialties, Navilyst Medical, Microsulis Medical, Vortex Medical and Clinical Devices
- The Special Committee of the Board of Directors of Landry’s Restaurants in the acquisition of Landry’s by Tilman J. Fertitta
- Celanese in the sale of its polyvinyl alcohol business to Sekisui Chemical Co.
- Trian Fund Management in its $166 million tender offer for shares of Wendy's/Arby's Group
- Pfizer in its $68 billion acquisition of Wyeth
- Bear Stearns in its acquisition by JPMorgan Chase & Co.
- Charming Shoppes in its proxy contest with Crescendo Investments
- Così, Inc. in its rights offering to common stockholders
- Trian Fund Management in its proxy contest with H.J. Heinz Company
- Wilshire Enterprises in its proxy contest with Bulldog Investors funds and subsequent self-tender offer to purchase half of Wilshire’s outstanding shares
- Gyrodyne Company of America in its proxy contest with Bulldog Investors funds
- Xstrata in its sale of its Noranda aluminum division to Apollo Management